Clinical Trial Update: Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 trial evaluated topical timolol 0.5% solution for proliferating infantile hemangiomas; the study was terminated and results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Hemangioma

Drugs mentioned

• Timolol 0.5% topical solution (Timolol)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Hemangioma, Infant | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2017-07-05